Compounds for treating alzheimer's disease

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 307/10 (2006.01) A61K 31/427 (2006.01) C07C 311/08 (2006.01) C07D 213/40 (2006.01) C07D 277/28 (2006.01) C07D 285/16 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2618481

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1 - R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.

La présente invention concerne des 1,2-éthylène diamines substituées de formule générale (I) dans laquelle les radicaux R1 à R13, A, B, L et i sont tels que définis dans la description ou dans les revendications, ainsi que leur utilisation pour traiter la maladie d'Alzheimer et des maladies similaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds for treating alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for treating alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for treating alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1982340

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.